STCUBE
Develops immuno-oncology therapies targeting novel immune checkpoints for cancer.
052020 | KO
Overview
Corporate Details
- ISIN(s):
- KR7052020005
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 영동대로 511 2201(삼성동, 무역센터 트레이드타워), 강남구
- Website:
- https://www.stcube.com/en/
Description
STCube is a biopharmaceutical company specializing in the research and development of innovative immuno-oncology therapies. The company focuses on discovering treatments that target novel immune checkpoints to overcome cancer's immune evasion mechanisms. Its primary area of research involves BTN1A1, a novel immune checkpoint target often expressed in a mutually exclusive manner with PD-L1. STCube's lead drug candidate, Nelmastobart, is a first-in-class anti-BTN1A1 immune checkpoint inhibitor. This therapy is being developed to provide a new treatment option for patients with treatment-resistant, refractory, or recurrent cancers that have limited therapeutic alternatives. The company utilizes a precision-medicine, biomarker-driven approach in its clinical development programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-08-27 00:00 |
기타경영사항(특허권취득)(자율공시)
|
Korean | 5.7 KB | ||
| 2021-08-13 00:00 |
반기보고서 (2021.06)
|
Korean | 1.3 MB | ||
| 2021-05-25 00:00 |
기타경영사항(특허권취득)(자율공시)(DUAL FUNCTION ANTIBODIES SPECIFIC TO GLYCOSYLATED PD-L1 AND…
|
Korean | 5.8 KB | ||
| 2021-05-17 00:00 |
분기보고서 (2021.03)
|
Korean | 1.2 MB | ||
| 2021-03-29 00:00 |
정기주주총회결과
|
Korean | 19.6 KB | ||
| 2021-03-19 00:00 |
감사보고서제출
|
Korean | 24.7 KB | ||
| 2021-03-19 00:00 |
사업보고서 (2020.12)
|
Korean | 492.7 KB | ||
| 2021-03-15 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 104.8 KB | ||
| 2021-03-15 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2021-03-15 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2021-03-09 00:00 |
주주총회소집공고
|
Korean | 163.7 KB | ||
| 2021-03-09 00:00 |
의결권대리행사권유참고서류
|
Korean | 161.4 KB | ||
| 2021-03-08 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 40.3 KB | ||
| 2021-02-25 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 9.0 KB | ||
| 2021-02-25 00:00 |
주주총회소집결의
|
Korean | 8.1 KB |
Automate Your Workflow. Get a real-time feed of all STCUBE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for STCUBE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for STCUBE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
